1. Home >
  2. M&A >
  3. Merger >
  4. NuvinkaDx Acquires GeneProof

M&A Deal Summary

NuvinkaDx Acquires GeneProof

On April 21, 2022, NuvinkaDx acquired life science company GeneProof

Acquisition Highlights
  • This is NuvinkaDx’s 1st transaction in the Life Science sector.
  • This is NuvinkaDx’s 1st transaction in Czech Republic.

M&A Deal Summary
Date 2022-04-21
Target GeneProof
Sector Life Science
Buyer(s) NuvinkaDx
Deal Type Merger

Target

GeneProof

Brno, Czech Republic
GeneProof is a molecular diagnostics company. GeneProof is a producer of PCR reagents and distributes its portfolio of more than 70 CE-marked molecular diagnostic tests and instruments throughout Europe, Africa, the Middle East, and South America. GeneProof was founded in 2005 and is based in Brno, Czech Republic.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

NuvinkaDx

Salem, New Hampshire, United States
Category Company
Sector Life Science
DESCRIPTION

NuvinkaDx is a global diagnostics company, brings established expertise in immunodiagnostics and molecular diagnostics. NuvinkaDx is based in Salem, New Hampshire.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 2 of 2
Country: Czech Republic M&A 1 of 1
Year: 2022 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-21 ALPCO

Salem, New Hampshire, United States

ALPCO is an importer and distributor of immunoassay-based products for the North American life science markets. ALPCO is a provider of proprietary and distributed diagnostics solutions, with over 60 collaborating partners from around the globe. ALPCO was founded in 1990 and is based in Salem, New Hampshire.

Buy -
Mergr

Solution for

Product

Company

Legal